Mark Bertolini Sells 591,168 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 591,168 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $29.28, for a total value of $17,309,399.04. Following the completion of the sale, the chief executive officer directly owned 8,990,566 shares in the company, valued at approximately $263,243,772.48. This represents a 6.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Down 1.4%

OSCR stock traded down $0.42 on Monday, reaching $29.37. 5,787,135 shares of the company traded hands, compared to its average volume of 7,824,008. The firm has a fifty day simple moving average of $23.03 and a 200-day simple moving average of $17.37. The company has a market cap of $8.85 billion, a P/E ratio of -49.78, a price-to-earnings-growth ratio of 2.08 and a beta of 2.37. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $30.66. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the previous year, the company posted $0.92 earnings per share. The company’s revenue for the quarter was up 52.6% compared to the same quarter last year. Research analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Quarry LP increased its position in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the last quarter. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the period. Strs Ohio bought a new position in Oscar Health in the first quarter worth approximately $30,000. Fifth Third Bancorp boosted its stake in shares of Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the last quarter. Finally, Binnacle Investments Inc bought a new stake in shares of Oscar Health during the 2nd quarter valued at $75,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Weiss Ratings cut Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday. UBS Group boosted their price target on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and lifted their price target for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. Finally, Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a report on Thursday, June 4th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.78.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.